Alden Ward, a truck driver with a history of epilepsy, takes anticonvulsant drugs and has had no seizures for seven years. The Secretary of Transportation nonetheless has denied Ward’s request to waive a Department of Transportation (DOT) safety rule that disqualifies those with a history of epilepsy from driving trucks in interstate commerce. See 49 U.S.C. app. § 2505(a)(3) (authorizing Secretary to issue safety regulations); 49 C.F.R. § 391.-41(b)(8) (regulations prohibiting anyone with an “established medical history or clinical diagnosis of epilepsy” from driving commercial vehicles in interstate commerce); 49 U.S.C. app. § 2505(f) (authorizing waiver of DOT safety regulations). Mr. Ward now appeals DOT’s waiver denial. He claims that it violates Section 504 of the federal Rehabilitation Act, which says
No otherwise qualified individual with handicaps, ... shall by reason of her or his handicap, be _ subjected to discrimination ... under any program or activity conducted by any Executive agency....
29 U.S.C. § 794. In our view, the denial of a waiver does not violate the Act. We therefore affirm the Secretary’s determination.
I
Background
We can state the relevant legal, factual, and procedural background concisely. Since 1935 federal statutes have authorized the Secretary of Transportation to issue, and to enforce, regulations governing commercial motor vehicle safety. See *159 §~ 204(a)(1) and (2) of the Motor Carrier Act of 1935, 49 Stat. 543, 546 (1935) (current version at 49 U.S.C. app. § 2505(a)). A regulation, first issued pursuant to this statutory authority in 1939, now says that a
A person is physically qualified to drive a motor vehicle if that person ... [h]as no established medical history or clinical diagnosis of epilepsy....
49 C.F.R. § 391.41(b)(8). See 4 Fed.Reg. 2294, 2295-96 (1939) (~ 1.21(b), 1.31). A Department explanation of the section, which has appeared in the Federal Register from time to time since 1977, says that
It is the intent [of this section] to permanently disqualify a driver who has a medical history or clinical diagnosis of epilepsy.
42 Fed.Reg. 60082 (1977).
The petitioner, Alden Ward, has a history of epileptic seizures. Anticonvulsant medicine, however, has kept those seizures under control; he has had no seizures at all since 1984; and, he worked without incident as a truck driver until May 1989. At that time Ward's employer discovered his epileptic history and suspended him from his job, as DOT's regulation requires.
Mr. Ward then asked DOT to waive application of its regulation in his case. He pointed out that DOT's Secretary has the legal power to
waive ... application of any regulation if the Secretary determines that such waiver is not contrary to the public interest and is consistent with the safe operation of commercial motor vehicles.
49 U.S.C. app. § 2505(f). He submitted medical information showing that his convulsions had last occurred nearly six years earlier, that even then they were infrequent and nocturnal, and that anticonvul-sant medicines effectively controlled them. He submitted a statement from his doctor to the effect that he should be permitted to drive a truck. And, he submitted a statement from Dr. Allan Krumholz, a nationally recognized expert on epilepsy who had served on a 1988 DOT medical "regulation-reevaluating" task force. Dr. Krumholz also said, in effect, that DOT should permit Ward to drive, and he added that, in his view, "the exclusion of individuals who are taking anti-epileptic or anticonvulsant medications from commercial driving is also wrong."
DOT initially pointed out that it currently was revising its "epilepsy-related" rules in light of the 1988 Task Force's recommendations, and it suggested that Ward simply participate in that rule-making proceeding. Ward noted, however, that rule-making and rule-revising can take a long time and that he needed his truck-driving job, so he asked DOT to rule on his waiver request. DOT then pointed (1) to the conceded fact that he was taking anti-convulsant medicine, (2) to the 1988 Task Force's recommendation against permitting those taking seizure-control medicine to drive, and (3) to the basic "anti-epileptic" regulation. It denied the waiver request. Ward appeals that denial. He says that DOT failed to give his case the "individualized consideration" that the Rehabilitation Act requires, see 29 U.S.C. § 794; School Board of Nassau County v. Arline,
II
Reviewability
The Government initially argues that we cannot review the legality of the Department's decision to deny Ward a waiver. The Government concedes that courts may review the legality of almost any final agency action that adversely affects a private citizen. 5 U.S.C. § 702; Abbott Laboratories v. Gardner,
if the Secretary determines that such waiver is not contrary to the public interest and is consistent with the safe operation of motor vehicles.
49 U.S.C. app. § 2505(f). It concludes that this discretionary authority is so broad, that, in effect, a reviewing court has “no law to apply.” Hence, a waiver decision falls within the “committed to agency discretion” exception, and the law forbids review.
The short, nearly conclusive, answer to this claim, however, is that there is “law to apply.” Mr. Ward says that the Department’s refusal to grant him a waiver violates the Rehabilitation Act, an Act that applies to the Department’s decisions, including decisions not to grant a waiver,
see Cousins v. Secretary of the United States Dept. of Transportation,
Although the Department’s broad “waiver” powers might mean that a private citizen, denied a waiver, would find it very difficult to show illegality based on the legal theory of “abuse of discretion,” 5 U.S.C. § 706(2)(A), the breadth of that power does not limit our practical ability to review this particular Rehabilitation Act issue. We can decide the Rehabilitation Act question in the “waiver” context as easily as in most other contexts. And, as far as we can tell, our doing so does not impose upon the agency an unusually heavy burden
(i.e.,
a burden significantly heavier than the burden that judicial review imposes in other contexts).
Cf., e.g., Heckler v. Chaney,
The Supreme Court has sometimes used language that (out of context) might suggest that broad statutory authority, leaving the courts without “law to apply,” could deprive the court of power to review other claims as well.
See, e.g., Citizens to Preserve Overton Park, Inc. v. Volpe,
Ill
The Rehabilitation Act
Mr. Ward’s basic claim is that DOT, in denying him a waiver, violated the Rehabilitation Act — an Act that makes it unlawful for DOT to forbid him from driving trucks “by reason of ... his handicap,”
i.e.,
his epilepsy, if he is “otherwise qualified” to drive. (We suspect that, in this context, we should read the word “otherwise” to mean “nonetheless,” for “otherwise,” in its ordinary sense, means “without the handicap” in which case virtually every handicapped person would be “otherwise qualified.”) He points out that in
Arline,
Of course, DOT did “individualize” its inquiry to some extent. It did not simply rely upon its absolute “anti-epilepsy” rule. It noted that a recent 1988 DOT medical task force had recommended that those with epilepsy be permitted to drive if they had had no seizures and had not taken anticonvulsant drugs for ten years. DOT asked Ward to submit
complete copies of [his] ... medical records related to the diagnosis and treatment of his epilepsy, and a copy of his complete driving record....
DOT concluded from this information that Ward had been seizure-free for six years, but that he took anticonvulsant drugs. Noting that the Task Force recommended against an exception in such circumstances, it denied the waiver. The question before us is whether DOT could rely upon the general statement embodied in the Task Force conclusion, or whether the Act required it to make a more detailed and individualized inquiry into Ward’s particular circumstances, in effect deciding whether it might be safe to permit driving by at least some epileptics who are seizure-free but use anticonvulsant drugs.
In our view, the Supreme Court’s post-
Arline
case,
Traynor v. Turnage,
The Supreme Court, in Traynor, rejected the petitioners’ argument
that § 504 mandates an individualized determination of ‘willfulness’ with respect to each veteran who claims to have been disabled by alcoholism.
does not demand inquiry into whether factors other than mental illness rendered an individual veteran’s drinking so entirely beyond his control as to negate any degree of ‘willfulness’ where Congress and the Veterans’ Administration have reasonably determined for purposes of the veterans’ benefits statutes that no such factors exist.
Id.
at 551,
would saddle the Government with additional administrative and financial burdens that Congress could not have contemplated in extending § 504 to federal programs.
Id.
at 551 n. 12,
Arline,
in stating that in “most cases” there should be an “individualized inquiry,”
For one thing, the petitioner here, as in Traynor, seeks an “individualized inquiry” that would permit him to escape the application of a general agency rule that would otherwise act as a handicap-based disqualification. In a sense, this case, like Tray-nor, involves distinctions among different categories of handicapped persons, distinctions which, in petitioner’s view, will remove a subcategory of such handicapped persons from a more general category that penalizes him. For another thing, the burden of individualizing DOT’s “waiver application” inquiries, beyond what the agency has done already, would seem significant. The parties seem to disagree, not about any individual facts concerning petitioner’s health, but about whether the Task Force's recommendation to disqualify those who, like petitioner, take anticonvulsant medicine, is a sound recommendation — a matter more fit for a rule-making, than for a rule-waiver, proceeding (see page 164, infra).
Further, as in
Traynor,
Congress has enacted legislation that suggests some degree of awareness of, involvement in, or approval of the relevant regulation. In
*163
Traynor,
the Court found approval in the fact that Congress, enacting the “willfulness” language
before
it enacted the Rehabilitation Act, referred in legislative history to the YA’s longstanding rules interpreting that word as excluding most alcoholism.
See Traynor,
We must concede that, in this last-mentioned respect (the degree of congressional consideration), we see potential distinctions between this case and Traynor. We do not know that Congress, in 1984, actually thought about the epilepsy regulation or its relation to unwarranted discrimination (although it also seems unlikely that anyone in Congress thought about this matter in respect to alcoholism in 1979 when Congress enacted the Rehabilitation Act). In any event, as we said, we doubt that the Act (even as interpreted in Arline) requires individual inquiry to the point where doing so is unreasonably burdensome (taking account not only of administrative needs but also of Rehabilitation Act policies). Our doubt, plus the strong similarity between this case and Traynor, leads us to apply here the legal standard that Traynor suggests. We therefore ask whether DOT’s reliance upon a general Task Force recommendation (to deny a waiver to those with epilepsy who must take anti-seizure medicine) was reasonable in light of both the administrative difficulties of further inquiry in the waiver context and the antidis-criminatory policies embodied in the Rehabilitation Act.
After examining the record, we conclude that DOT’s refusal, without making further “individualized inquiry,” to grant a waiver was reasonable for the following reasons. First, DOT did inquire into some of Mr. Ward’s individual characteristics. It determined that, although he had a history of epilepsy, he had not had a seizure for many years, but that he controlled his seizures through the use of anticonvulsant medicine.
Second, DOT relied upon a narrow version of its historic anti-epilepsy rule. It referred to its 1988 Task Force Report. That Report, unlike the pre-existing rule, would permit a narrow class of those with a history of epilepsy to drive commercial vehicles, namely those individuals without seizures for ten years who do not use drugs to control the seizures. That Task Force Report also concluded, however, that individuals with “Diagnosed Epilepsy Taking Anticonvulsant Medications with Seizures Controlled” should “not be authorized to drive commercial interstate vehicles.”
Third, the Task Force Report’s conclusion itself seems a reasonable one. The question about whether seizure-free epileptics taking anticonvulsant medicine should be authorized to drive commercial vehicles is obviously a close one. The Task Force Report itself points out that the risks of seizure or accident are extraordinarily low. It says that the risk of such an individual having an epileptic seizure while driving is “possibly at or even below baseline rates,” i.e., less than the risk that a person who has never had epilepsy will suddenly have a seizure while at the wheel. (This latter risk itself is very low: in any given year about 50 out of 10,000 white males will have a heart attack; about five out of 10,000 white males will have an epileptic seizure.) Yet, the Report goes on to say that the risk may be somewhat higher for truck drivers who keep odd hours or eat irregularly. And, it adds that the risk is low only if the individual actually takes his medicine; he may forget. The Report, af *164 ter describing the very low risk, reasons as follows:
Nonetheless, these individuals are exposed to conditions previously discussed [i.e., irregular sleeping and eating conditions] which in and of themselves increase the risk for seizures in seizure-prone individuals. In addition, the inconsistent access to medical care may cause difficulty in the evaluation of acute problems which may increase the risk for seizure occurrence, and the acquisition of replacement anticonvulsant medication if drugs are lost or forgotten, place such individuals at some increase in risk. These individuals should not be authorized to drive commercial interstate vehicles. It is impossible to predict which of these individuals may have seizures should they inadvertently miss a dosage of medication. However, this issue requires further investigation and should be reassessed in the future when more data is collected.
The record does not permit us to conclude that this argument is an unreasonable one.
Fourth, the Task Force’s position also suggests that further “individualized” investigation of Mr. Ward’s individual case is most unlikely to provide reasons for believing he can drive commercial trucks safely; rather, further general studies and investigations, designed to turn up general features tending to show greater, or lesser, degrees of risk, are what the Task Force seems to think are required.
Fifth, DOT says that it “plans to initiate a further review of the epilepsy rule based on the ... conference report.” DOT added that it would place the materials that Mr. Ward submitted, including the letter from Dr. Krumholz (who served on the Task Force), “in the public docket which we are opening on this subject.” The nature of the inquiry that the Task Force suggested seems well suited to a general rule-making inquiry, for it likely involves consideration of risk rates, special features of different cases that may change those rates, and possible alternative ways of accommodating those in Mr. Ward’s situation. A more thorough examination of Ward s case alone would seem less likely to shed light on the proper way for DOT to deal either with Ward himself or with those who share his circumstances. Of course, a change in the rule may help only those others; it may come too late to help Mr. Ward. But, given the nature of the problem and the Task Force recommendation, DOT’S procedural decision, like its substantive decision, is reasonable.
We conclude that DOT could reasonably decide not to investigate Mr. Ward’s case further and that it could rely upon the Task Force’s general, recommended rule in denying him a waiver from its rule forbidding those with a history of epilepsy to drive commercial vehicles in interstate commerce. Its decision is
Affirmed.
